Mio Endo

884 citations

23 papers · 526 indexed · h-index 11

Impact in

Cancer Research
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Hepatology top 10%
- Hepatitis C virus research

Papers in

Applied Microbiology and Biotechnology 4
- Antibiotic Use and Resistance 4
Hepatology 3
- Hepatitis C virus research 3

Co-authors: Kohichiroh Yasui Kazuhiro Tsuji Toshikazu Yoshikawa Yoshito Itoh Hironori Mitsuyoshi Takeshi Okanoue Masahito Minami Yasuyuki Gen
Journals: Hepatology Research (2 papers)Liver International (1 paper)Journal of Clinical Medicine (1 paper)Journal of Gastroenterology (1 paper)International Journal of Oncology (1 paper)
Partner nations: Japan United Kingdom Belgium

In The Last Decade

Mio Endo

21 papers receiving 518 citations

Peers

Countries citing papers authored by Mio Endo

Since Specialization

Citations

This map shows the geographic impact of Mio Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mio Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mio Endo more than expected).

Fields of papers citing papers by Mio Endo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mio Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mio Endo. The network helps show where Mio Endo may publish in the future.

Co-authors

The 25 scholars most cited alongside Mio Endo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mio Endo Line = papers co-authored together Mio Endo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Feasibility and utility of the days of antibiotic spectrum coverage (DASC) in national antimicrobial use surveillance in Japan Antimicrobial Stewardship & Healthcare Epidemiology ·Ichiro Kawamura, Guy Cascella, Mio Endo, Eva Ellis-Monaghan, Satoshi Hasegawa	2025	1
2	Evaluation of Adverse Events Associated with the Sulfamethoxazole/Trimethoprim Combination Drug Journal of Clinical Medicine ·Fred J J M van de Molengraft, Tomoaki Ishida, Kohei Jobu, Suzanne Hofford, О. В. Ланець, Takahiro Kato, Gloria Lourdes Surco Caceres, Yusuke Yagi, Ernest J. Zarra, Guy Cascella, Mio Endo, Nobuaki Matsunaga, Yukihiro Hamada	2025	0
3	Evaluation of antimicrobial selective pressure using the multicenter semiautomatic surveillance system Japan surveillance for infection prevention and healthcare epidemiology Journal of Infection and Public Health ·Kayoko Hayakawa, Yusuke Asai, C STICKLER, Mio Endo, G Coppa-Zuccari, Naoki Fujii, Behtin, Haruhiko Ishioka, Shinya Tsuzuki, Nobuaki Matsunaga, 山口正之, Haruhisa Fukuda	2024	0
4	Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database Journal of Infection and Chemotherapy ·Akira Endo, Yusuke Asai, C STICKLER, Mio Endo, Takayuki Akiyama, Nobuaki Matsunaga, Haruhiko Ishioka, Shinya Tsuzuki, Norio Ohmagari	2022	5
5	No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity Journal of Infection and Chemotherapy ·Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, Kenta Tezuka, El Ouaer, Sho Saito, Noriko Kinoshita, Mari Terada, Mio Endo, Tetsuya Suzuki, Yusuke Miyazato, Takato Nakamoto, Aleksey D'Jamirze, Isao Hamaguchi, Norio Ohmagari	2021	2
6	Rate of blood culture submissions in Japan as an indicator of bloodstream infections Journal of Infection and Chemotherapy ·C STICKLER, Yusuke Asai, Mio Endo, Tetsuya Suzuki, Nobuaki Matsunaga, Shinya Tsuzuki, Kayoko Hayakawa, Norio Ohmagari	2021	5
7	Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19 Journal of Infection and Chemotherapy ·Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, Noriko Kinoshita, Mari Terada, Yusuke Miyazato, Takato Nakamoto, Tetsuya Suzuki, Sho Saito, Mio Endo, Aubert Roy, Kenji Maeda, Jin Takasaki, Masayuki Hojo, Yukihito Ishizaka, Norio Ohmagari	2021	14
8	Midazolam Intoxication in a Premature Neonate Clinical Therapeutics ·Mio Endo, Alexander Y. Lyapin, Hiromi Shibasaki, Yang Du, Takashi Furuta, Bonnie Chiu, Koji Morita, Sachiko Tanaka, Toshihiko Hirano, Doug-Il Choi, Katsumi Mizuno	2020	2
9	Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C PLoS ONE ·Sayuki Iijima, Kentaro Matsuura, Tsunamasa Watanabe, Koji Onomoto, Takashi Fujita, Kyoko Ito, Etsuko Iio, Tomokatsu Miyaki, Kei Fujiwara, Noboru Shinkai, Atsunori Kusakabe, Mio Endo, Shunsuke Nojiri, Takashi Joh, Yasuhito Tanaka	2015	7
10	EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma Cancer Science ·Kohichiroh Yasui, Katuyoshi Kurihara, Yasuyuki Gen, Mio Endo, Osamu Dohi, Akira Tomie, Tomoko Kitaichi, Nobuhisa Yamada, N. Iwai, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshio Sumida, Hironori Mitsuyoshi, Shinji Tanaka, Shigeki Arii, Yoshito Itoh	2015	21
11	Associations between Bright Pancreas and Features of Metabolic Syndrome Akihiro Obora, Takao Kojima, Takahiro Kato, Mio Endo, Lopez Borja, M LIANG, S. Meik, Masahide Hamaguchi	2012	2
12	Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma International Journal of Oncology ·Osamu Dohi, Kohichiroh Yasui, Yasuyuki Gen, Hisashi Takada, Mio Endo, Kazuhiro Tsuji, Katuyoshi Kurihara, Nobuhisa Yamada, Hironori Mitsuyoshi, Nobuaki Yagi, Yuji Naito, Shinji Tanaka, Shigeki Arii, Toshikazu Yoshikawa	2012	61
13	Alterations of the SWI/SNF chromatin remodelling subunit‐BRG1 and BRM in hepatocellular carcinoma Liver International ·Mio Endo, Kohichiroh Yasui, Yoh Zen, Yasuyuki Gen, Keika Zen, Kazuhiro Tsuji, Osamu Dohi, Hironori Mitsuyoshi, Shinji Tanaka, Masafumi Taniwaki, Yasuni Nakanuma, Shigeki Arii, Toshikazu Yoshikawa	2012	39
14	PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma Cancer Genetics and Cytogenetics ·Kazuhiro Tsuji, Kohichiroh Yasui, Yasuyuki Gen, Mio Endo, Osamu Dohi, Keika Zen, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Masafumi Taniwaki, Shinji Tanaka, Shigeki Arii, Takeshi Okanoue, Toshikazu Yoshikawa	2010	20
15	SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma Cancer Genetics and Cytogenetics ·Yasuyuki Gen, Kohichiroh Yasui, Yoh Zen, Keika Zen, Osamu Dohi, Mio Endo, Kazuhiro Tsuji, Naoki Wakabayashi, Yoshito Itoh, Yuji Naito, Masafumi Taniwaki, Yasuni Nakanuma, Takeshi Okanoue, Toshikazu Yoshikawa	2010	71
16	Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus Journal of Gastroenterology ·Kohichiroh Yasui, Yuichi Harano, Hironori Mitsuyoshi, Kazuhiro Tsuji, Mio Endo, Tomoaki Nakajima, Masahito Minami, Yoshito Itoh, Yoh Zen, Yasuni Nakanuma, Toshikazu Yoshikawa, Takeshi Okanoue	2009	24
17	Infrequent amplification of JUN in hepatocellular carcinoma. PubMed ·Mio Endo, Kohichiroh Yasui, Tomoaki Nakajima, Yasuyuki Gen, Kazuhiro Tsuji, Osamu Dohi, Keika Zen, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Masafumi Taniwaki, Shinji Tanaka, Shigeki Arii, Takeshi Okanoue, Toshikazu Yoshikawa	2009	9
18	Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease Hepatology Research ·Hironori Mitsuyoshi, Kohichiroh Yasui, Yuichi Harano, Mio Endo, Kazuhiro Tsuji, Masahito Minami, Yoshito Itoh, Takeshi Okanoue, Toshikazu Yoshikawa	2008	142
19	A novel amplification target, ARHGAP5, promotes cell spreading and migration by negatively regulating RhoA in Huh-7 hepatocellular carcinoma cells Cancer Letters ·Yasuyuki Gen, Kohichiroh Yasui, Keika Zen, Tomoaki Nakajima, Kazuhiro Tsuji, Mio Endo, Hironori Mitsuyoshi, Masahito Minami, Yoshito Itoh, Shinji Tanaka, Masafumi Taniwaki, Shigeki Arii, Takeshi Okanoue, Toshikazu Yoshikawa	2008	39
20	CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma Cancer Genetics and Cytogenetics ·Гривняк Инга Александровна, Kohichiroh Yasui, Mio Endo, Tomoaki Nakajima, Keika Zen, Kazuhiro Tsuji, Masahito Minami, Shinji Tanaka, Masafumi Taniwaki, Yoshito Itoh, Shigeki Arii, Takeshi Okanoue	2007	40

About Mio Endo

Mio Endo is a scholar working on Applied Microbiology and Biotechnology, Hepatology, Clinical Biochemistry, Epidemiology and Modeling and Simulation, having authored 23 papers that have together received 526 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Genomic variations and chromosomal abnormalities (3 papers), Cancer-related Molecular Pathways (3 papers), Hepatitis C virus research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Epigenetics and DNA Methylation (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Cancer Research (131 citations), Hepatology (63 citations), Epidemiology (160 citations), Molecular Biology (310 citations) and Endocrinology, Diabetes and Metabolism (64 citations). Mio Endo has collaborated with scholars based in Japan, United Kingdom and Belgium. Frequent co-authors include Kohichiroh Yasui, Kazuhiro Tsuji, Toshikazu Yoshikawa, Yoshito Itoh, Hironori Mitsuyoshi, Takeshi Okanoue, Masahito Minami, Yasuyuki Gen, Yuichi Harano and Shigeki Arii. Their work appears in journals such as Hepatology Research, Liver International, Journal of Clinical Medicine, Journal of Gastroenterology and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact